LEADER 01763oam  2200541   450 
001 9910706981403321
005 20181010151230.0
035   $a(CKB)5470000002459661
035   $a(OCoLC)1030308978
035   $a(EXLCZ)995470000002459661
100   $a20180403d2018      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFentanyl $ethe next wave of the opioid crisis : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 21, 2017
210  1$aWashington :$cU.S. Government Publishing Office,$d2018.
215   $a1 online resource (iii, 234 pages) $cillustrations, maps
300   $a"Serial No. 115-16."
320   $aIncludes bibliographical references.
517   $aFentanyl 
606   $aOpioid abuse$zUnited States
606   $aOpioid abuse$zUnited States$xPrevention
606   $aDrug addiction$xTreatment$zUnited States
606   $aDrugs$xTherapeutic use$zUnited States
606   $aDrugs$xOverdose$zUnited States
606   $aDrug control$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aOpioid abuse
615  0$aOpioid abuse$xPrevention.
615  0$aDrug addiction$xTreatment
615  0$aDrugs$xTherapeutic use
615  0$aDrugs$xOverdose
615  0$aDrug control
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCF
801  2$bMERUC
801  2$bUOK
801  2$bGPO
801  2$bINT
801  2$bGPO
906   $aBOOK
912   $a9910706981403321
996   $aFentanyl$93478658
997   $aUNINA